Jacobio Pharmaceuticals Group Balance Sheet Health
Financial Health criteria checks 5/6
Jacobio Pharmaceuticals Group has a total shareholder equity of CN¥1.1B and total debt of CN¥73.6M, which brings its debt-to-equity ratio to 6.9%. Its total assets and total liabilities are CN¥1.5B and CN¥387.1M respectively.
Key information
6.9%
Debt to equity ratio
CN¥73.62m
Debt
| Interest coverage ratio | n/a |
| Cash | CN¥1.15b |
| Equity | CN¥1.07b |
| Total liabilities | CN¥387.11m |
| Total assets | CN¥1.46b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: JBPH.F's short term assets (CN¥1.2B) exceed its short term liabilities (CN¥205.1M).
Long Term Liabilities: JBPH.F's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥182.0M).
Debt to Equity History and Analysis
Debt Level: JBPH.F has more cash than its total debt.
Reducing Debt: JBPH.F's debt to equity ratio has increased from 0% to 6.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: JBPH.F has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: JBPH.F has sufficient cash runway for 2.6 years if free cash flow continues to reduce at historical rates of 45.5% each year.